yourstate.us
Home / United States / 21 CFR
21 CFR 556.346

§ 556.346 Laidlomycin.

United States · 21 CFR — Food and Drugs · Status: effective

Get this as JSONEmbed this
Cite this
Citation
21 CFR 556.346, § 556.346 Laidlomycin, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87782
Permanent ID
ys:prov:87782@1
SHA-256
7319b9a66fca830247a33846710aabd09c7d43b731fa79274f956c695cc5ee9f

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Acceptable daily intake (ADI). The ADI for total residue of laidlomycin is 7.5 µg/kg of body weight per day. (b) Tolerances. The tolerance for laidlomycin (marker residue) is: (1) Cattle. Liver (target tissue): 0.2 ppm. (2) [Reserved] (c) Related conditions of use. See § 558.305 of this chapter.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.